PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsOrbec
Orbec
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
230 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AsthmaD001249EFO_0000270J45626452327124
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.97414101549
Obstructive lung diseasesD008173HP_000653641128934
Lung diseasesD008171HP_0002088J98.41147527
Allergic rhinitisD065631J30.923123423
RhinitisD012220EFO_0008521J3123123423
Allergic rhinitis seasonalD006255EFO_0003956J3013418
Respiratory soundsD012135HP_0010307R06.1134
Respiratory tract diseasesD012140213
Respiratory hypersensitivityD0121301113
Show 19 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Graft vs host diseaseD006086D89.8114318
Allergic rhinitis perennialD012221EFO_1001417J30.89628
Respiratory aspirationD053120EFO_10018391113
Bronchopulmonary dysplasiaD001997P27.81113
SinusitisD012852EFO_0007486J32112
BronchiectasisD001987HP_0002110J4711
RhinosinusitisD00009682511
FolliculitisD005499111
CroupD003440EFO_0007227J05.011
LaryngitisD00782711
Show 1 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Covid-19D000086382123
LeukemiaD007938C95122
Myelodysplastic syndromesD009190D46122
Myeloproliferative disordersD009196D47.1122
Multiple myelomaD009101C90.0122
LymphomaD008223C85.9122
Plasma cell neoplasmsD054219122
PreleukemiaD011289122
PlasmacytomaD010954C90.3122
SyndromeD013577122
Show 65 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HivD00667811
PharmacokineticsD01059911
Eosinophilic esophagitisD057765EFO_0004232K20.011
EsophagitisD004941HP_0100633K2011
Respiratory distress syndromeD012128EFO_1000637J8011
Acute lung injuryD055371EFO_000461011
Newborn respiratory distress syndromeD012127P2211
BronchiolitisD001988HP_001195011
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Ulcerative colitisD003093EFO_0000729K5111
ColitisD003092EFO_0003872K52.911
UlcerD014456MPATH_57911
SmokingD012907EFO_000431811
ObesityD009765EFO_0001073E66.911
GlaucomaD005901EFO_0000516H4011
Intraocular pressureD00742911
Medication adherenceD055118EFO_000634411
CoughD003371HP_0012735R0511
Chronic coughD00009682211
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name
INN
Description
Classification
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL ID
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use